Craig B. Granowitz
2022
In 2022, Craig B. Granowitz earned a total compensation of $1.6M as Senior Vice President and Chief Medical Officer at Lexicon Pharmaceuticals, a 66% increase compared to previous year.
Compensation breakdown
| Bonus | $189,520 |
|---|---|
| Option Awards | $631,881 |
| Salary | $467,459 |
| Stock Awards | $268,000 |
| Other | $14,162 |
| Total | $1,571,022 |
Granowitz received $631.9K in option awards, accounting for 40% of the total pay in 2022.
Granowitz also received $189.5K in bonus, $467.5K in salary, $268K in stock awards and $14.2K in other compensation.
Rankings
In 2022, Craig B. Granowitz's compensation ranked 2,124th out of 5,542 executives tracked by ExecPay. In other words, Granowitz earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,124 out of 5,542 | 62nd |
Division Manufacturing | 1,137 out of 3,000 | 62nd |
Major group Chemicals And Allied Products | 490 out of 1,350 | 64th |
Industry group Drugs | 450 out of 1,253 | 64th |
Industry Pharmaceutical Preparations | 325 out of 907 | 64th |
Source: SEC filing on March 26, 2024.
Granowitz's colleagues
We found four more compensation records of executives who worked with Craig B. Granowitz at Lexicon Pharmaceuticals in 2022.